Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Kisqali for HR-positive HER-negative advanced or metastatic breast cancer

July 19, 2018

Vyriad collaborates with Merck KGaA and Pfizer to study Voyager-V1 with avelumab

July 19, 2018

Incyte studies INCB-054707 for hidradenitis suppurativa in phase II trial

July 19, 2018

KDDF grant will support evaluation of Hyleukin-7 with Keytruda in triple-negative breast cancer

July 19, 2018

RPL28 gene polymorphism tied to reduced survival in FOLFIRI-treated mCRC patients

July 19, 2018

Chinese phase III trial of GV-971 in Alzheimer's disease meets primary endpoint

July 19, 2018

Beta cells make and secrete autoimmune peptides

July 19, 2018

Positive interim data presented from a phase II/III study of marzeptacog alfa

July 19, 2018

Topline data presented from phase III trial of tanezumab

July 19, 2018

Takeda and Ovid announce expansion of the clinical program for TAK-935

July 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....